Why is Dhampur Bio falling/rising?

As of 03-Sep, Dhampur Bio Organics Ltd is currently priced at 88.42, reflecting a slight decrease of 0.07, or 0.08%. The stock has shown a positive trend over the past week and month, with returns of +3.97% and +11.36%, respectively. However, it has significantly underperformed in the long term, with a year-to-date return of -22.81% and a one-year return of -38.60%. Today's performance indicates that the stock has underperformed its sector by 0.53%, although it is trading above its moving averages across various time frames. Despite a rise in investor participation, with delivery volume increasing by 87.8% against the five-day average, the stock's fundamentals are concerning. The company has a low return on equity and a high debt-to-EBITDA ratio, which raises questions about its long-term viability and profitability.
In the broader market context, while the Sensex has shown a slight decline of 0.04% over the past month, Dhampur Bio's performance has been markedly better in the short term, indicating some resilience against the broader market trends. However, the stock's substantial decline over the past year, compared to the market's negative return of -2.41%, highlights its struggles. The lack of domestic mutual fund investment suggests a lack of confidence in the company's future prospects, further contributing to its downward pressure. Overall, the combination of weak long-term fundamentals and poor performance relative to the market has led to the stock's current decline.